↓ Skip to main content

Dove Medical Press

A Potent EGFR Inhibitor, N-Phenyl Pyrazoline Derivative Suppresses Aggressiveness and Cancer Stem Cell-Like Phenotype of Cervical Cancer Cells

Overview of attention for article published in Drug Design, Development and Therapy, July 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
17 Mendeley
Title
A Potent EGFR Inhibitor, N-Phenyl Pyrazoline Derivative Suppresses Aggressiveness and Cancer Stem Cell-Like Phenotype of Cervical Cancer Cells
Published in
Drug Design, Development and Therapy, July 2022
DOI 10.2147/dddt.s350913
Pubmed ID
Authors

Mustofa, Pamungkas Bagus Satriyo, Artania Adnin Tri Suma, Stephanus Satria Wira Waskitha, Tutik Dwi Wahyuningsih, Eti Nurwening Sholikhah

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 18%
Student > Ph. D. Student 2 12%
Unspecified 1 6%
Researcher 1 6%
Lecturer 1 6%
Other 0 0%
Unknown 9 53%
Readers by discipline Count As %
Chemistry 3 18%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Unspecified 1 6%
Agricultural and Biological Sciences 1 6%
Medicine and Dentistry 1 6%
Other 0 0%
Unknown 10 59%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 July 2022.
All research outputs
#22,774,430
of 25,392,582 outputs
Outputs from Drug Design, Development and Therapy
#1,757
of 2,270 outputs
Outputs of similar age
#374,279
of 439,890 outputs
Outputs of similar age from Drug Design, Development and Therapy
#36
of 51 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,270 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 439,890 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 51 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.